Синтез мономеров полиамидных миметиков нуклеиновых кислот и исследование их свойств (1091937), страница 17
Текст из файла (страница 17)
E., Egholm M., Berg R. H., Buchardt O. Sequence-selective recognition ofDNA by strand displacement with a thymine-substituted polyamide. // Science. – 1991. – V. 254.– P. 1497-1500.2.Corradini R., Sforza S., Tedeschi T, Totsingan F., Manicardi A., Marchelli R. PeptideNucleic Acids with a Structurally Biased Backbone.
Updated Review and Emerging Challenges.// Curr. Top. Med. Chem. – 2011. – V. 11(12). – P. 1535-1554.3.Zhou P., Wang M., Du L., Fisher G. W., Waggoner A., Ly D. H. Novel Binding andEfficient Cellular Uptake of Guanidine-Based Peptide Nucleic Acids (GPNA). // J. Am. Chem.Soc. – 2003. – V. 125. – P. 6878-6879.4.Sahu B., Chenna V., Lathrop K. L., Thomas S. M., Zon G., Livak K. J., Ly D.
H.Synthesis of conformationally preorganized and cell-permeable guanidine-based γ-peptidenucleic acids (γGPNAs). // J. Org. Chem. – 2009. – V. 74(4). – P. 1509-1516.5.Боярская Н. П. Синтез тиминсодержащих отрицательно заряженных пептидно-нуклеиновых кислот различного строения и исследование их гибридизационныххарактеристик. // диссертация на соискание ученой степени кандидата химических наук.
–02.00.10. – 2007. – Москва.6.Баранов А. В. Разработка методов синтеза псевдопептидов и мономеров пептидно-нуклеиновых кислот. // диссертация на соискание ученой степени кандидата химическихнаук. – 02.00.10. – 2008. – Москва.7.Льянов М. А. Синтез и изусение свойств хиральных пептидно-нуклеиновых кислот.// диссертация на соискание ученой степени кандидата химических наук.
– 02.00.10. –2011. – Москва.8.Dias N., Stein C. A. Antisense Oligonucleotides: Basic Concepts and Mechanisms. //Mol. Can. Ther. – 2002. – V. 1. – P. 347-355.9.Juliano R., Bauman J., Kang H., Ming X. Biological Barriers to Therapy with Antisenseand siRNA Oligonucleotides. // Mol. Pharm.
– 2009. – V. 6(3). – P. 686-695.10.Crooke S. T., Vickers T., Lima W., Wu H. Mechanisms of Antisense Drug Action, anIntroduction. In Antisense drug technology: principles, strategies, and applications. // ed. S. T.Crooke, CRC Press. – 2008. – 2nd ed. – P. 3-46.11.Resnier P., Montier T., Mathieue V., Benoit J.-P., Passirani C. A review of the currentstatus of siRNA nanomedicines in the treatment of cancer.
// Biomaterials. – 2013. – V. 34. – I.27. – P. 6429-6443.8812.Koch T., Rosenbohm C., Hansen H.F., Hansen B., Straarup E.M., Kauppinen S. LockedNucleic acids: Properties and therapeutic aspects. In Therapeutic Oligonucleotides. // ed. J.Kurreck, RSC Publishing. – 2008. – P.
103-141.13.Summerton J. Morpholino antisense oligomers: the case for an RNase H-independentstructural type. // Biochim. et Bioph. Acta. – 1999. – V. 1489.– P. 141-158.14.Miller P. S. Development of antisense and antigene oligonucleotide analogs. In Progressin Nucleic Acid Research and Molecular Biology. // eds. Cohn W. E., Moldave K., Academicpress. – 1996.
– V. 52. – P. 263-291.15.Verma S., Eckstein F. Modified oligonucleotides: Synthesis and Strategy for Users. //Annu. Rev. Biochem. – 1998. – V. 67. – P. 99-134.16.Marugg J. E., de Vroom E., Dreef C. E., Tromp M., van der Marel G. A., van Boom J. H.Synthesis of nucleic acid methylphosphonates via the 1-hydroxybenzotriazole phosphtriesterapproach. // Nucl. Acids Res. – 1986. – V. 14(5).
– P. 2171-2185.17.Miller P. S., Ts’o P. O. P., Hogrefe R. I., Reynolds M. A., Arnold L. J. Jr. Anticodeoligonucleoside methylphosphonates and their psoralen derivatives. In Antisense Research andApplications. // eds. S. T. Crooke, B. Lebleu, CRC Press. – 1993. – P. 189-204.18.Miller P. S., Dreon N., Pulford S.
M., McParland K. B. Oligothymidylate AnaloguesHaving Stereoregular, Alternating Methylphosphonate/Phosphodiester Backbones. // J. Biol.Chem. – 1980. – V. 255(20). – P. 9659-9665.19.Hamma T., Miller P. S. Interactions of Hairpin Oligo-2'-O-MethylribonucleotidesContaining Methylphosphonate Linkages with HIV TAR RNA. // Antisense and Nucl. AcidDrug Development. – 2003. – V.
13. – P. 19-30.20.Miller P. S., McParland K. B., Jayaraman K., Ts’o P. O. P. Biochemical and BiologicalEffects of Nonionic Nucleic Acid Methylphosphonates. // Biochemistry. – 1981. – V. 20. – P.1874-1880.21.Chem T.-L., Miller P. S., Ts'o P. O. P., Colvin O. M. Disposition and metabolism ofoligodeoxynucleoside methylphosphonate following a single in vivo injection in mice.
// DrugMetab. Disposit. – 1990. – V. 18. – P. 815-818.22.Ma C.-H., Kachroo A. H., Macieszak A., Chen T.-Y., Guga P., Jayaram M. // Reactionsof Cre with Methylphosphonate DNA: Similarities and Contrasts with Flp and VacciniaTopoisomerase. // PLoS ONE. – 2009. – V. 4(9). – e7248. – P. 1-12.23.Buck H. M. The Chemical and Biochemical Properties of Methylphosphotriester DNAand RNA in Comparison with Their Corresponding Methylphosphonates. A Dynamic ModelDescription.
// Nucleosides, Nucleotides and Nucleic Acids. – 2007. – V. 26(2). – P. 205-222.8924.Wozniak L. A., Gora M., Stec W. J. Chemoselective Activation of Nucleoside 3'-O-Methylphosphonothioates with 1,3,5-Triazinyl Morpholinium Salts. // J. Org. Chem. – 2007. –V. 72. – P. 8584-8587.25.Šípová H., Špringer T., Rejman D., Šimák O., Petrová M., Novák P., Rosenbergová Š.,Páv O., Liboska R., Barvík I., Štěpánek J., Rosenberg I., Homola J. 5′-O-Methylphosphonatenucleic acids – new modified DNAs that increase the Escherichia coli RNase H cleavage rate ofhybrid duplexes. // Nucl. Acids Res.
– 2014. – V. 42(8). – P. 5378–5389.26.Di W., Ferreira R. A. S., Willinger M. C., Ren X., Pinna N. Enhanced PhotoluminescenceFeatures of Rare Earth Phenylphosphonate Hybrid Nanostructures Synthesized underNonaqueous Conditions. // J. Phys. Chem. C. – 2010. – V. 114(14). – P. 6290-6297.27.Sobczak M., Johansson T., Bulkowski M., Sochacki M., Lavén G., Mikolaczyk B.,Stawinski J., Nawrot B.
DNA oligonucleotides with stereodefined phenylphosphonate andphosphonothioate internucleotide bonds: synthesis and physico-chemical properties. //ARKIVOC. – 2012. – V. IV. – P. 63-79.28.Cohen J. S. Phosphorothioate oligodeoxynucleotides. In Antisense Research andApplications. // eds. S. T. Crooke, B. Lebleu, CRC Press. – 1993. – P. 205-222.29.Tomaszewska A., Guga P., Stec W.
J. Diastereomerically Pure Nucleoside-5'-O-(2-thio-4,4-pentamethylene-1,3,2-oxathiaphospholane)s – Substrates for Synthesis of P-ChiralDerivatives of Nucleoside-5'-O-phosphorothioates. // Chirality. – 2011. – V. 23. – P. 237-244.30.De Mesmaeker A., Altmann K.-H., Waldner A., Wendeborn S. Backbone modificationsin oligonucleotides and peptide nucleic acid systems. // Cur. Opinion in Struct. Biol. – 1995. – V.5(3). – P.
343-355.31.BennettC.F.PharmacologicalPropertiesof2'-O-Methoxyethyl-ModifiedOligonucleotides. In Antisense drug technology: principles, strategies, and applications. // ed. S.T. Crooke, CRC Press. – 2008. – 2nd ed. – P. 273-304.32.Olesiak M., Okruszek A. Studies of Asymmetric Induction in the Synthesis ofDinucleoside Phosphorothioates from 2-Oxo-1,3,2-dithiaphospholane Nucleoside Derivatives. //Phosphorus, Sulfur, and Silicon. – 2009. – V.
184. – P. 1548-1560.33.Amirkhanov N. V., Zarytova V. F. // Synthesis of the 3'-derivatives of phodphorothioateoligonucleotide analouges. // Nucleosides & Nucleotides. – 1995. – V. 14(3-5). – P. 935-937.34.Stec W. J., Zon G., Egan W., Stec, B. Automated solid-phase synthesis, separation, andstereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides. // J. Am.
Chem. Soc.– 1984. – V. 106(20). – P. 6077-6079.35.Iyer R. P.; Egan W.; Regan, J. B.; Beaucage, S. L. 3H-1,2-Benzodithiole-3-one 1,l-DioxideasanImprovedSulfurizingReagentintheSolid-PhaseSynthesisof90Oligodeoxyribonucleide Phosphorothioates. // J. Am. Chem. Soc. – 1990. – V.112. – P. 12531254.36.Chrisey L. A., Walz S. E., Pazirandeh M., Campbell J. R. Internalization ofOligodeoxyribonucleotidesbyVibrioparahaemolyticus.//AntisenseResearchandDevelopment. – 1993. – V.
3(4). – P. 367-381.37.BrillW.K.-D.,NielsenJ.,CaruthersM.H.SynthesisofDinucleosidePhosphorodithioates via Thioamidites. // Tetrahedron Letters. – 1988. – V. 29(43). – P. 55175520.38.Hayakawa Y., Hirabayashi Y., Hyodo M., Yamashita S., Matsunami T., Cui D.-M.,Kawai R., Kodama H. A Strategy for the stereoselective preparation of thymidinephosphorothioates with the (R) or the (S) configuration at the stereogenic phosphorus atom andtheir application to the synthesis of oligodeoxyribonucleotides with stereochemically purephosphate/phosphorothioate chimeric backbones.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
